Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SIROLIMUS vs SITAGLIPTIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SIROLIMUS vs SITAGLIPTIN: Safety Overview

Metric SIROLIMUS SITAGLIPTIN
Total FAERS Reports 11,371 19,904
Deaths Reported 1,737 2,412
Death Rate 15.3% 12.1%
Hospitalizations 3,535 6,668
Average Patient Age 43.1 yrs 67.3 yrs
% Female Patients 45.4% 52.3%
FDA Approval Date Aug 22, 2002 Dec 30, 2025
Manufacturer Zydus Lifesciences Limited A-S Medication Solutions
Route ORAL ORAL
Marketing Status Prescription Prescription